EUVIMEDEUVIMED entdecken
Kohortenstudie

COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study

Pierre-Etienne Heudel, Virginie Avrillon, Benedicte Mastroianni, Helen Boyle, Souad Assaad, Isabelle Ray-Coquard, Jean-Philippe Spano, Sylvie Chabaud, Claire Cropet, Maurice Perol, Jean-Yves Blay

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.116770 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Pierre-Etienne Heudel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Centre Léon Bérard, 28, rue Laënnec, Lyon Cedex 08 69373, France. Hauptthemen laut MEDLINE: Neoplasms, Immune Checkpoint Inhibitors, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: European Commission, French National Research Agency, French National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmune Checkpoint InhibitorsCOVID-19 VaccinesCOVID-19HumansFemaleMaleMiddle AgedAgedSARS-CoV-2AdultCohort StudiesAged, 80 and overVaccination

Stichwörter der Autor:innen

COVID-19CancerImmune checkpoint inhibitorsMRNA vaccineSurvivalVaccination

Substanzen

Immune Checkpoint InhibitorsCOVID-19 Vaccines

Autor:innen und Institutionen

  • Medical Oncology Department, Centre Léon Bérard, 28, rue Laënnec, Lyon Cedex 08 69373, France.
  • Medical Oncology Department, Pitié Salpétriere, APHP, Paris 75013, France.
  • Medical Oncology Department, Centre Léon Bérard, 28, rue Laënnec, Lyon Cedex 08 69373, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.

Förderung

  • European Commission
  • French National Research Agency
  • French National Cancer Institute

Zitieren

APA

Heudel, P. E., Avrillon, V., Mastroianni, B., Boyle, H., Assaad, S., Ray-Coquard, I., Spano, J. P., Chabaud, S., Cropet, C., Perol, M., & Blay, J. Y. (2026). COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116770

Vancouver

Heudel PE, Avrillon V, Mastroianni B, Boyle H, Assaad S, Ray-Coquard I, et al. COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116770

BibTeX
@article{Heudel2026,
  author = {Heudel, Pierre-Etienne and Avrillon, Virginie and Mastroianni, Benedicte and Boyle, Helen and Assaad, Souad and Ray-Coquard, Isabelle and Spano, Jean-Philippe and Chabaud, Sylvie and Cropet, Claire and Perol, Maurice and Blay, Jean-Yves},
  title = {COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.116770}
}
Kostenlos starten →